7051-27-6 Usage
Molecular Structure
The compound is composed of a phenyl group, a benzimidazole ring, and a trifluoromethyl group. This unique structure contributes to its potential pharmacological properties and makes it a promising candidate for drug discovery and development.
Ethanol Derivative
As an ethanol derivative, the compound has a hydroxyl (-OH) group attached to a carbon chain. This feature is important for its solubility and reactivity, as well as its potential interactions with biological targets.
Trifluoromethyl Group
The presence of a trifluoromethyl group in the compound enhances its lipophilicity, which can improve its ability to cross cell membranes and interact with intracellular targets. This property may be beneficial for the compound's pharmacokinetics and pharmacodynamics.
Potential Applications in Medicinal Chemistry
Due to its unique structure and potential pharmacological properties, 1-phenyl-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]ethanol may have potential uses in drug discovery and development. It could be used as a lead compound for the design of new pharmaceutical compounds with biological activity.
Further Research
While the compound shows promise, further research is needed to fully understand its properties and potential applications. This includes studying its bioavailability, toxicity, and efficacy in various biological assays, as well as exploring its potential mechanisms of action.
Chemical Stability
The compound's stability under various conditions, such as temperature, pH, and the presence of other chemicals, is an important factor to consider for its potential use in pharmaceutical formulations.
Synthesis and Purification
The synthesis and purification methods for 1-phenyl-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]ethanol are crucial for obtaining a pure and well-characterized compound. This is essential for conducting accurate biological and pharmacological studies.
Biological Activity
The compound's biological activity, including its potential targets and mechanisms of action, needs to be investigated to determine its therapeutic potential and possible side effects.
Pharmacokinetics and Pharmacodynamics
Understanding the compound's pharmacokinetics (absorption, distribution, metabolism, and excretion) and pharmacodynamics (efficacy and side effects) is essential for its development as a potential drug candidate.
Safety and Toxicity
The safety and toxicity profile of 1-phenyl-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]ethanol must be assessed to ensure that it is suitable for use in humans and to identify any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 7051-27-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,5 and 1 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7051-27:
(6*7)+(5*0)+(4*5)+(3*1)+(2*2)+(1*7)=76
76 % 10 = 6
So 7051-27-6 is a valid CAS Registry Number.
